{
  "scenario_id": "healthcare_genomic_data_analytics_platform_2025",
  "context": "Major healthcare system implementing advanced genomic data analytics platform for personalized medicine initiatives",
  "stakeholders": {
    "requester": "Chief Medical Information Officer",
    "approvers": ["CEO", "Chief Medical Officer", "Board of Directors"],
    "influencers": ["Genetics Department", "IT Security", "Research Ethics Committee"]
  },
  "request": {
    "amount": "$18,000,000",
    "purpose": "Deploy enterprise genomic data analytics platform for clinical decision support and research",
    "urgency": "medium",
    "justification": "Enable precision medicine capabilities and improve patient outcomes through genomic insights"
  },
  "decision_process": [
    {
      "stage": "clinical_requirements_assessment",
      "duration": "2 months",
      "activities": ["Clinical workflow analysis", "Use case prioritization", "Stakeholder engagement"],
      "outcome": "Comprehensive requirements defined for oncology and cardiology applications"
    },
    {
      "stage": "technology_evaluation",
      "duration": "3 months",
      "activities": ["Platform evaluation", "Integration testing", "Security assessment"],
      "outcome": "Leading genomic analytics platform selected with strong clinical validation"
    },
    {
      "stage": "privacy_and_compliance_review",
      "duration": "2 months",
      "activities": ["HIPAA compliance review", "Data privacy assessment", "Ethical considerations"],
      "outcome": "Comprehensive privacy framework established with audit trails"
    },
    {
      "stage": "implementation_planning",
      "duration": "2 months",
      "activities": ["Phased rollout plan", "Training program development", "Change management strategy"],
      "outcome": "12-month implementation plan approved with clinical oversight"
    }
  ],
  "business_impact": {
    "expected_benefits": ["Improved treatment outcomes", "Reduced adverse drug reactions", "Enhanced research capabilities"],
    "projected_revenue": "Cost savings of $25M annually through optimized treatments",
    "risk_factors": ["Data privacy concerns", "Clinical adoption challenges", "Technology integration complexity"]
  }
}